// App-Quantinova.ai

423 : Treatment of relapsed and refractory lymphomas with nivolumab in a limited recourse country

Researchers

Presenter

  • Lusine Harutyunyan

Principal Investigators

  • Anahit Ter-Grigoryan

  • Hayk Grigoryan

  • Marina Kazaryan

  • Miranush Saaryan

  • Nerses Ghahramanyan

  • Artem Oganesyan

  • Levon Evoyan

  • Marina Melik-Andreasyan

  • Anahit Aynajyan

  • Karapet Hakobyan

  • Astghik Voskanyan

  • Karen Meliksetyan

  • Yervand Hakobyan

Medical Centers

  • Armenian Hematology Association, Yerevan, Armenia

  • Hematology Center aft. Prof. R. Yeolyan, Yerevan, Armenia; National Institute of Health, Yerevan, Armenia

Locations

  • Armenia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hodgkin's Lymphoma

  • Lymphomas

Biomarkers

  • N/A

Drug/Treatment

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved